by Dole Baker, MD, FAAOA Having been a long-time member of the AAOA, recent upgrades in the AAOA member benefits make me pause to consider the value. Most medical societies offer journals and CME. It is par for the course. …
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here: